Royal Bank of Canada’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,748
| Closed | -$783K | – | 7497 |
|
|
2020
Q3 | $783K | Sell |
5,748
-1,049
| -15% | -$112K | ﹤0.01% | 3468 |
|
|
2020
Q2 | $657K | Buy |
6,797
+244
| +4% | +$20.4K | ﹤0.01% | 3544 |
|
|
2020
Q1 | $307K | Sell |
6,553
-2,183
| -25% | -$140K | ﹤0.01% | 4009 |
|
|
2019
Q4 | $637K | Buy |
8,736
+2,116
| +32% | +$128K | ﹤0.01% | 3790 |
|
|
2019
Q3 | $346K | Sell |
6,620
-64
| -1% | -$3.4K | ﹤0.01% | 4074 |
|
|
2019
Q2 | $335K | Buy |
6,684
+1,233
| +23% | +$60K | ﹤0.01% | 4129 |
|
|
2019
Q1 | $283K | Buy |
5,451
+5,432
| +28,589% | +$250K | ﹤0.01% | 4134 |
|
|
2018
Q4 | $1K | Sell |
19
-951
| -98% | -$52.4K | ﹤0.01% | 6652 |
|
|
2018
Q3 | $63K | Buy |
970
+969
| +96,900% | +$57K | ﹤0.01% | 5120 |
|
|
2018
Q2 | $0 | Sell |
1
-175
| -99% | -$8.47K | ﹤0.01% | 6914 |
|
|
2018
Q1 | $9K | Buy |
176
+174
| +8,700% | +$9.04K | ﹤0.01% | 5772 |
|
|
2017
Q4 | $0 | Sell |
2
-1,535
| -100% | -$59.2K | ﹤0.01% | 7095 |
|
|
2017
Q3 | $66K | Buy |
1,537
+1,499
| +3,945% | +$47.8K | ﹤0.01% | 5262 |
|
|
2017
Q2 | $0 | Sell |
38
-462
| -92% | -$6.09K | ﹤0.01% | 6915 |
|
|
2017
Q1 | $7K | Buy |
500
+165
| +49% | +$2.11K | ﹤0.01% | 6119 |
|
|
2016
Q4 | $4K | Buy |
+335
| New | +$5.16K | ﹤0.01% | 6380 |
|
Royal Bank of Canada's MYOK Position: Q4 2020 in Review
Royal Bank of Canada sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,748 shares — an estimated $783K sold.
Royal Bank of Canada first reported a position in MYOK in Q4 2016 and held it in 16 quarters. The position peaked at $783K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Royal Bank of Canada reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Royal Bank of Canada sold 5,748 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $783K.
- Royal Bank of Canada first reported a position in MyoKardia, Inc. Common Stock in Q4 2016 and held it in 16 quarters.
- Royal Bank of Canada's MyoKardia, Inc. Common Stock position peaked at $783K in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.